UBS Group AG - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$288,724
+683.4%
68,418
+475.5%
0.00%
Q2 2023$36,856
+405.5%
11,889
+126.7%
0.00%
Q1 2023$7,291
-80.7%
5,245
-72.4%
0.00%
Q4 2022$37,777
-30.0%
18,983
-28.6%
0.00%
Q3 2022$54,000
+54.3%
26,575
+138.4%
0.00%
Q2 2022$35,000
-31.4%
11,145
-9.7%
0.00%
Q1 2022$51,000
-71.3%
12,338
-66.9%
0.00%
Q4 2021$178,000
+201.7%
37,320
+239.3%
0.00%
Q3 2021$59,000
-42.7%
11,000
-45.7%
0.00%
Q2 2021$103,000
+39.2%
20,242
+84.0%
0.00%
Q1 2021$74,000
-70.0%
11,000
-79.6%
0.00%
Q4 2020$247,000
+50.6%
54,049
+27.9%
0.00%
Q3 2020$164,000
-57.6%
42,263
-48.1%
0.00%
Q2 2020$387,000
+800.0%
81,446
+560.0%
0.00%
Q1 2020$43,000
+59.3%
12,340
+124.4%
0.00%
Q4 2019$27,000
+22.7%
5,500
-27.9%
0.00%
Q3 2019$22,000
-86.8%
7,628
-67.2%
0.00%
Q2 2019$167,000
-71.5%
23,273
-43.8%
0.00%
Q1 2019$586,000
-42.4%
41,427
-44.9%
0.00%
Q4 2018$1,018,000
-8.0%
75,218
+50.7%
0.00%
Q3 2018$1,107,000
+18.9%
49,897
-12.0%
0.00%
Q2 2018$931,00056,7270.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$90,819,89014.58%
Eversept Partners, LP 2,644,988$11,161,8490.94%
TPG GP A, LLC 12,328,767$52,027,3970.90%
Nantahala Capital Management 2,212,757$9,337,8350.80%
Rubric Capital Management LP 4,024,500$16,983,3900.64%
Hedges Asset Management LLC 84,600$357,0120.31%
Signature Wealth Management Partners, LLC 66,666$281,3310.28%
Tejara Capital Ltd 96,672$407,9560.23%
Tranquilli Financial Advisor LLC 71,414$301,3670.22%
EAM Investors, LLC 230,271$971,7440.19%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders